Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.
作者信息
Havasi Andrea, Doros Gheorghe, Sanchorawala Vaishali
机构信息
Department of Nephrology, Boston University School of Medicine, Boston, Massachusetts.
Amyloidosis Center, Boston University School of Medicine, Boston, Massachusetts.
出版信息
Am J Hematol. 2018 May;93(5):E129-E132. doi: 10.1002/ajh.25066. Epub 2018 Feb 24.
Abstract
摘要
相似文献
1
Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.高剂量美法仑和干细胞移植治疗AL淀粉样变性中新的肾脏反应标准的预测价值。
Am J Hematol. 2018 May;93(5):E129-E132. doi: 10.1002/ajh.25066. Epub 2018 Feb 24.
2
Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation.新的肾脏分期系统在接受大剂量美法仑和干细胞移植治疗的AL淀粉样变性中的验证
Am J Hematol. 2016 Oct;91(10):E458-60. doi: 10.1002/ajh.24464. Epub 2016 Jul 14.
3
High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.高剂量马法兰和干细胞移植治疗因免疫球蛋白轻链淀粉样变性和单克隆免疫球蛋白沉积病而接受透析的患者。
Biol Blood Marrow Transplant. 2018 Jan;24(1):127-132. doi: 10.1016/j.bbmt.2017.08.031. Epub 2017 Sep 1.
4
High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis.高剂量美法仑和自体外周血造血干细胞移植治疗 AL 淀粉样变性。
Acta Haematol. 2020;143(4):381-387. doi: 10.1159/000506498. Epub 2020 Apr 3.
5
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.自体干细胞移植后t(11;14)轻链（AL）淀粉样变性的预后：新疗法的基准
Blood Cancer J. 2023 Nov 15;13(1):170. doi: 10.1038/s41408-023-00945-0.
6
The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation.骨髓浆细胞负荷对接受大剂量美法仑和自体干细胞移植的轻链淀粉样变性患者生存的影响。
Biol Blood Marrow Transplant. 2016 Sep;22(9):1729-1732. doi: 10.1016/j.bbmt.2016.05.027. Epub 2016 Jun 11.
7
Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis.严重低白蛋白血症对AL淀粉样变性患者大剂量美法仑毒性及自体干细胞移植的影响。
Bone Marrow Transplant. 2016 Oct;51(10):1318-1322. doi: 10.1038/bmt.2016.132. Epub 2016 May 16.
8
The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency.一名患有AL淀粉样变性和严重X因子缺乏症的患者接受VAD加SCT治疗后的长期结局
Intern Med. 2018 Mar 1;57(5):701-706. doi: 10.2169/internalmedicine.9263-17. Epub 2017 Nov 1.
9
Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience.轻链淀粉样变性患者自体干细胞移植的肾脏结局：西班牙单中心经验
Amyloid. 2017 Mar;24(sup1):70-71. doi: 10.1080/13506129.2017.1293646.
10
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.瑞典大剂量美法仑和自体干细胞移植治疗AL淀粉样变性的结果，1994 - 2009年所有接受治疗患者的长期结果
Bone Marrow Transplant. 2016 Dec;51(12):1569-1572. doi: 10.1038/bmt.2016.249. Epub 2016 Oct 3.
引用本文的文献
1
The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era.《克隆战争：现代时代的诊断与治疗异常蛋白血症性肾病》
J Clin Med. 2021 Apr 12;10(8):1633. doi: 10.3390/jcm10081633.
本文引用的文献
1
Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation.新的肾脏分期系统在接受大剂量美法仑和干细胞移植治疗的AL淀粉样变性中的验证
Am J Hematol. 2016 Oct;91(10):E458-60. doi: 10.1002/ajh.24464. Epub 2016 Jul 14.
2
Renal risk and response in amyloidosis.淀粉样变性的肾脏风险和反应。
Blood. 2014 Oct 9;124(15):2315-6. doi: 10.1182/blood-2014-08-596338.
3
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.AL 淀粉样变性中用于评估肾脏结局和化疗早期肾脏反应标志物的分期系统。
Blood. 2014 Oct 9;124(15):2325-32. doi: 10.1182/blood-2014-04-570010. Epub 2014 Aug 12.
4
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.大剂量美法仑和自体干细胞移植后 AL 淀粉样变性的结果：一系列 421 例患者的长期结果。
Blood. 2011 Oct 20;118(16):4346-52. doi: 10.1182/blood-2011-01-330738. Epub 2011 Aug 9.
5
Outcome in renal Al amyloidosis after chemotherapy.肾淀粉样变性症化疗后的结果。
J Clin Oncol. 2011 Feb 20;29(6):674-81. doi: 10.1200/JCO.2010.30.5235. Epub 2011 Jan 10.
6
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.免疫球蛋白轻链淀粉样变性（AL）中器官受累及治疗反应的定义：2004年4月18 - 22日于法国图尔举行的第10届国际淀粉样变性和淀粉样变研讨会的共识意见
Am J Hematol. 2005 Aug;79(4):319-28. doi: 10.1002/ajh.20381.
7
Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.大剂量静脉注射美法仑及自体血干细胞移植对AL淀粉样变性相关肾病的影响。
Ann Intern Med. 2001 May 1;134(9 Pt 1):746-53. doi: 10.7326/0003-4819-134-9_part_1-200105010-00011.
Zotero 插件